Exploring how m6A mRNA methylation affects aging in pancreatic beta cells and diabetes
Official title: Interrogating the role of m6A mRNA methylation in the aging of the β-cell and diabetes
Funded at University of Chicago · NIH-11245924 · Data updated 2026-11-12
This study is looking at how a specific chemical change in the genetic material of insulin-producing cells in the pancreas affects their aging and function, especially in people with Type 1 and Type 2 diabetes, to find new ways to help these cells work better and survive longer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | May 1, 2025 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $249,000 |
| NIH project number | 4R00DK135927-03 |
| Project ID | NIH-11245924 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults diagnosed with Type 1 or Type 2 diabetes, particularly those experiencing age-related decline in beta cell function.
✕Less likely to help
Patients without diabetes or those with other unrelated health conditions may not benefit from this research.
What this research studies
This research investigates the role of m6A mRNA methylation in the aging of pancreatic beta cells, which are crucial for insulin production. By examining how changes in m6A methylation contribute to the decline in beta cell function associated with aging and diabetes, the study aims to identify potential therapeutic targets. The researchers will utilize advanced techniques to analyze the m6A landscape in beta cells from individuals with Type 1 and Type 2 diabetes. This could lead to new strategies for improving beta cell survival and function in diabetic patients.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that enhance beta cell function and longevity, potentially improving diabetes management.
How similar studies have gone: Previous research has shown promising results in targeting RNA modifications for therapeutic purposes, indicating potential success for this novel approach.
Where this research is happening
-
University of Chicago
Chicago, United States Active
Researchers
- Principal investigator: F de Jesus, Dario — University of Chicago
- Study coordinator: F de Jesus, Dario
Related research
Other NIH-funded projects on the same topics.
-
Multimodal bioelectroceutical approach to bone regeneration in diabetes and aging
A new approach uses electrical signals and tiny drugs inside special scaffolds to help jawbone heal in people with diabetes or aging-related bone problems.
-
Silver linings in midlife for women with HIV and diabetes
A short, friendly study looks at how women with HIV, diabetes, or both find positive meaning and stay engaged with care during perimenopause and menopause.
-
RNA m6A changes that age insulin-making beta cells in diabetes
This work explores whether changes in a common RNA chemical mark called m6A cause aging and loss of function in insulin-producing beta cells in adults with type 1 or type 2 diabetes.
-
Understanding how inflammation affects diabetes in older adults
This study is looking at how long-term inflammation and diabetes are related in older adults, especially how aging and nutrition might play a role, and it hopes to find ways to help seniors stay healthier by understanding these connections better.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Retinal signals in early diabetes and how they affect vision
This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.